Shivang Sunil Parikh, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ghrelin | 1 | 2022 | 255 | 0.700 |
Why?
|
| Skin | 3 | 2024 | 4479 | 0.490 |
Why?
|
| Microphthalmia-Associated Transcription Factor | 5 | 2023 | 257 | 0.470 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2022 | 2945 | 0.400 |
Why?
|
| Anti-Mullerian Hormone | 2 | 2023 | 420 | 0.330 |
Why?
|
| Ultraviolet Rays | 3 | 2022 | 1099 | 0.300 |
Why?
|
| Melanosomes | 1 | 2024 | 34 | 0.230 |
Why?
|
| Melanoma | 5 | 2024 | 5696 | 0.220 |
Why?
|
| Antibody Affinity | 1 | 2024 | 251 | 0.210 |
Why?
|
| Antigens, Ly | 1 | 2024 | 297 | 0.210 |
Why?
|
| Laron Syndrome | 1 | 2022 | 1 | 0.200 |
Why?
|
| Ataxia Telangiectasia | 1 | 2023 | 107 | 0.200 |
Why?
|
| Ovarian Follicle | 1 | 2023 | 243 | 0.190 |
Why?
|
| Glucuronosyltransferase | 1 | 2022 | 136 | 0.190 |
Why?
|
| Germinal Center | 1 | 2024 | 379 | 0.190 |
Why?
|
| Appetite | 1 | 2022 | 247 | 0.170 |
Why?
|
| HIV Antibodies | 1 | 2024 | 1337 | 0.140 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2021 | 701 | 0.140 |
Why?
|
| Ovary | 1 | 2021 | 957 | 0.140 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2017 | 220 | 0.130 |
Why?
|
| MicroRNAs | 3 | 2021 | 3785 | 0.130 |
Why?
|
| Skin Diseases | 1 | 2024 | 1082 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2024 | 2454 | 0.120 |
Why?
|
| Adaptation, Physiological | 1 | 2021 | 1308 | 0.110 |
Why?
|
| Mice | 11 | 2024 | 81788 | 0.100 |
Why?
|
| DNA, Neoplasm | 1 | 2018 | 1740 | 0.100 |
Why?
|
| Weight Gain | 1 | 2022 | 2355 | 0.100 |
Why?
|
| Sexual Behavior | 1 | 2021 | 2192 | 0.090 |
Why?
|
| Tumor Microenvironment | 1 | 2024 | 3947 | 0.090 |
Why?
|
| B-Lymphocytes | 1 | 2024 | 4779 | 0.090 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2024 | 4639 | 0.090 |
Why?
|
| Testosterone | 1 | 2021 | 2495 | 0.090 |
Why?
|
| Animals | 12 | 2024 | 168730 | 0.080 |
Why?
|
| Skin Pigmentation | 2 | 2023 | 277 | 0.080 |
Why?
|
| Proteomics | 1 | 2022 | 3909 | 0.080 |
Why?
|
| Immunotherapy | 1 | 2024 | 4752 | 0.080 |
Why?
|
| Keratinocytes | 2 | 2024 | 863 | 0.080 |
Why?
|
| Melanocytes | 2 | 2024 | 504 | 0.070 |
Why?
|
| Skin Neoplasms | 3 | 2024 | 5837 | 0.070 |
Why?
|
| HIV-1 | 1 | 2024 | 6943 | 0.070 |
Why?
|
| Exercise | 1 | 2022 | 5937 | 0.060 |
Why?
|
| Cell Line, Tumor | 4 | 2024 | 17063 | 0.060 |
Why?
|
| Granulosa Cells | 1 | 2023 | 120 | 0.050 |
Why?
|
| Gene Knock-In Techniques | 1 | 2024 | 419 | 0.050 |
Why?
|
| Uridine Diphosphate | 1 | 2022 | 35 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2018 | 8601 | 0.050 |
Why?
|
| Estrus | 1 | 2021 | 70 | 0.050 |
Why?
|
| Glycosyltransferases | 1 | 2022 | 114 | 0.050 |
Why?
|
| Melanoma, Experimental | 1 | 2024 | 556 | 0.050 |
Why?
|
| Humans | 14 | 2024 | 765823 | 0.050 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2024 | 545 | 0.050 |
Why?
|
| Fibroblasts | 2 | 2024 | 4160 | 0.040 |
Why?
|
| Interferon Type I | 1 | 2024 | 567 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 3 | 2024 | 22323 | 0.040 |
Why?
|
| Cell Differentiation | 1 | 2017 | 11643 | 0.040 |
Why?
|
| Growth Hormone | 1 | 2022 | 567 | 0.040 |
Why?
|
| Mice, Transgenic | 2 | 2024 | 9548 | 0.040 |
Why?
|
| Gene Knockout Techniques | 1 | 2021 | 798 | 0.040 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 1 | 2019 | 184 | 0.040 |
Why?
|
| AIDS Vaccines | 1 | 2024 | 898 | 0.040 |
Why?
|
| Seasons | 1 | 2023 | 1523 | 0.040 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2019 | 394 | 0.030 |
Why?
|
| Cell Communication | 1 | 2024 | 1660 | 0.030 |
Why?
|
| Mammals | 1 | 2022 | 1125 | 0.030 |
Why?
|
| Cell Transdifferentiation | 1 | 2017 | 186 | 0.030 |
Why?
|
| Open Reading Frames | 1 | 2019 | 820 | 0.030 |
Why?
|
| Cell Line | 2 | 2019 | 15540 | 0.030 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2018 | 618 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2018 | 1643 | 0.030 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2022 | 1936 | 0.030 |
Why?
|
| Antibodies, Neutralizing | 1 | 2024 | 2010 | 0.030 |
Why?
|
| DNA Repair | 1 | 2023 | 2050 | 0.030 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2022 | 2057 | 0.030 |
Why?
|
| Female | 5 | 2024 | 396050 | 0.030 |
Why?
|
| Mutation | 1 | 2018 | 30188 | 0.030 |
Why?
|
| DNA Damage | 1 | 2023 | 2462 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2024 | 3503 | 0.030 |
Why?
|
| Neoplasms | 1 | 2022 | 22349 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2023 | 8278 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2021 | 4255 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2023 | 3430 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2017 | 1673 | 0.020 |
Why?
|
| Mitochondria | 1 | 2024 | 3670 | 0.020 |
Why?
|
| Glucose | 1 | 2022 | 4332 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2018 | 6110 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2018 | 4110 | 0.020 |
Why?
|
| Male | 3 | 2022 | 363740 | 0.020 |
Why?
|
| Macrophages | 1 | 2024 | 5771 | 0.020 |
Why?
|
| Insulin | 1 | 2022 | 6601 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2021 | 7599 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2022 | 12767 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2017 | 3604 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2019 | 4424 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2017 | 18970 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 9520 | 0.010 |
Why?
|
| Disease Progression | 1 | 2018 | 13613 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2023 | 23588 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2022 | 54798 | 0.010 |
Why?
|
| HIV Infections | 1 | 2024 | 17530 | 0.010 |
Why?
|